1. Singh HR, Paules M, Forbes TJ, Zilberman MV. Reversible dilated cardiomyopathy and neuroblastoma. J Pediatr. 2005; 147:271.
Article
2. Lee YH, Lee HD, Lee YA, Lee YS, Jung JA, Hwang GG, et al. Ganglioneuroblastoma presenting as dilated cardiomyopathy. Arch Dis Child. 2003; 88:162–4.
Article
3. Carlson P, Jefferies JL, Kearney D, Russell H. Refractory dilated cardiomyopathy associated with metastatic neuroblastoma. Pediatric Blood Cancer. 2010; 55:736–8.
Article
4. Kato M, Hirata S, Kikuchi A, Ogawa K, Kishimoto H, Hanada R. Neuroblastoma presenting with dilated cardiomyopathy. Pediatr Blood Cancer. 2008; 50:391–2.
Article
5. Kwok SY, Cheng FW, Lo AF, Leung WK, Yam MC, Li CK. Variants of cardiomyopathy and hypertension in neuroblastoma. J Pediatr Hematol Oncol. 2014; 36:e158–61.
Article
6. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons Do. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990; 63:234–7.
Article
7. Suh IW, Lee CW, Kim YH, Hong MK, Lee JW, Kim JJ, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in Pheochromocytoma. J Korean Med Sci. 2008; 23:350–4.
Article
8. Shiraishi I, Nishimura K, Sakaguchi H, Abe T, Kitano M, Kurosaki K, et al. Acute rupture of chordate tendineae of the mitral valve in infants: a nationwide survey in Japan exploring a new syndrome. Circulation. 2014; 130:1053–61.